The award recognizes Lipkin’s decades of significant contributions to public health and the identification, prevention, and treatment of infectious disease outbreaks.
On Jan. 1, 2020, public health officials in the U.S. heard about a strange new virus in China. They didn't know what it was, but at Columbia University, Dr. Ian Lipkin was already nervous.
Scientists CII have created a next-generation sequencing (NGS) technology that employs oligonucleotides (oligos)—short single strands of synthetic DNA—as bait for relevant targets of detection.
Gilbert Smith, administrative director of Center for Infection and Immunity (CII), received Columbia University Irving Medical Center’s 2023 Baton Award.